III - Pharmacokinetics Flashcards

1
Q

Concentration of a drug at the receptor site

A

Effective Drug Concentrationh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The concentration at the receptor site is usually proportional to the drug’s concentration in the plasma or whole blood at equilibrium except for

A

topical drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Volume at which the drug would need to be uniformly distributed to produce an observed blood concentration

A

Apparent Volume of Distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Apparent Volume of Distribution =

A

Vd = amount of drug in the body/plasma drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Apparent Volume of Distribution can be altered by

A

liver or kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Distribution: Low Vd

A

blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Distribution: Medium Vd

A

extracellular space, body water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Distribution: High Vd

A

tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Relates the rate of elimination of the plasma concentration

A

Clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clearance =

A

Cl = rate of elimination/plasma drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clearance depends on

A

drug, condition of organs of elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clearance is a constant proportion

A

First-Order Kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clearance is a constant amount

A

Zero-Order Kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most important pharmacokinetic parameter to be considered in defining a rational steady state during dosage regimen

A

Clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Condition in which the average total amount of drug in the body does not change over multiple dosing intervals

A

Steady State

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rate of drug input equals the rate of elimination

A

Steady State

17
Q

Steady State is reached after _____ half-lives of the drug.

A

4-5

18
Q

Constant for drugs following first order kinetics

A

Half-Life

19
Q

Half-Life =

A

t1/2 = (0.693 x volume of distrubution)/clearance

20
Q

Fraction of the administered dose that reaches the systemic circulation

A

Bioavailability

21
Q

Drugs administered via _____ have 100% bioavailability.

A

IV

22
Q

Bioavailability is reduced by

A

incomplete absorption, first-pass metabolism, pre-systemic redistribution

23
Q

Bioavailability is determined by

A

computing the area under the plasma concentration curve (AUC)

24
Q

Plan for a drug administration over a time period

A

Dosage Regimen

25
Q

Dosage Regimen results in the achievement of _____ levels of the drug without exceeding _____.

A

therapeutic levels, minimum toxic concentration

26
Q

Equal to the rate of elimination at steady state

A

Maintenance Dose

27
Q

Maintenance Dose =

A

(clearance x desired plasma concentration)/bioavailability

28
Q

Important to maintain concentration above minimum therapeutic level

A

Maintenance Dose

29
Q

Not involved in calculating maintenance dose

A

Volume of Distribtion

30
Q

If the therapeutic concentration must be achieved rapidly and the volume of distribution is large

A

Loading Dose

31
Q

Not involved in calculating loading dose

A

Clearance

32
Q

Safe range between the minimum therapeutic concentration and the minimum toxic concentration of a drug

A

Therapeutic Window

33
Q

Adjustment of Dosage in Renal Impairment

A

Average Dose x Crea Clearance / 100mL/min

34
Q

Used to calculate the patient’s creatinine clearance

A

Cockroft-Gault Equation

35
Q

Cockroft-Gault Equation

A

[(140-age) x weight (kg)] / [72xcrea mg/dl] (x 0.85 in females)